Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model

Trifluridine/tipiracil (FTD/TPI) (a.k.a. TAS-102) is a combination drug for metastatic colorectal cancer (CRC) and severely pretreated metastatic gastric/gastroesophageal junction (GEJ) cancers, comprising FTD, a thymidine-based antineoplastic nucleoside analog, and TPI, which enhances FTD bioavaila...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsunekuni, Kenta, Kawakami, Hisato, Matsuoka, Kazuaki, Nagase, Hideki, Mitani, Seiichiro, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765280/
https://www.ncbi.nlm.nih.gov/pubmed/33333866
http://dx.doi.org/10.3390/jcm9124050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765280/
https://www.ncbi.nlm.nih.gov/pubmed/33333866
http://dx.doi.org/10.3390/jcm9124050

Ejemplares similares